Prolactin receptor signal transduction in cells of the immune system

Journal of Endocrinology

Volumn 157, Issue 2, 1998, Pages 187-197

  Clevenger, C V ^a   Freier, D O ^a   Kline, J B ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN RECEPTOR;

ANIMAL CELL; CELL PROLIFERATION; CELL SURVIVAL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; KILLER CELL; LYMPHOCYTE PROLIFERATION; NONHUMAN; OSMOREGULATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CYTOKINES; HUMANS; ISOMERISM; LYMPHOCYTES; PROLACTIN; PROTEIN-TYROSINE KINASES; RATS; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION;

EID: 0031809982     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1570187     Document Type: Review

References (112)

1. c chain. Blood 88 4118-4123.
2. Adams JM, Houston H, Allen J, Lints T & Harvey R 1992 The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene 7 611-618.
3. vav, in human hematopoietic cells. Journal of Biological Chemistry 267 18021-18025.
4. Ali S, Pellegrini I & Kelly PA 1991 A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. Journal of Biological Chemistry 266 20110-20117.
5. Ali S, Edery M, Pellegrini I, Lesueur L, Paly J, Djiane J & Kelly PA 1992 The Nb2 form of prolactin receptor is able to activate a milk protein gene promoter. Molecular Endocrinology 6 1242-1248.
6. Bailey AR & Burchett KR 1997 Effect of low-dose dopamine on serum concentrations of prolactin in critically ill patients. British Journal of Anaesthesia 78 97-99.
7. Bazan JF 1989 A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochemical and Biophysical Research Communications 164 788-795.
8. Bazan JF 1990 Haematopoietic receptors and helical cytokines. Immunology Today 11 350-354.
9. Benedetto N, Folgore A, Galdiero M, Meli R & DiCarol R 1995 Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis. Pathologie Biologie 43 395-400.
10. Berczi L, Nagy E, Kovacs K & Horvath E 1981 Regulation of humoral immunity in rats by pituitary hormones. Acta Endocrinologica 98 506-513.
11. Bernton HW, Meltzer MS & Holaday JW 1988 Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239 401-404.
12. Berwaer M, Martial JA & Davis JRE 1994 Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Molecular Endocrinology 8 635-642.
13. Boutin JM, Jolicoeur C, Okamura H, Gagnon J, Edery M, Shirota M, Banville D, Dusanter-Fourt I, Djiane J & Kelly PA 1988 Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53 69-77.
14. Boutin JM, Edery M, Shirota M, Jolicoeur C, Lesueur L, Ali S, Gould D, Djiane J & Kelly P 1989 Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Molecular Endocrinology 3 1455-1461.
15. Bustelo XR, Ledbetter JA & Barbacid M 1992 Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature 356 68-71.
16. Bustelo XR, Rubin SD, Suen K-L, Carasco D & Barbacid M 1993 Developmental expression of the vav protooncogene. Cell Growth and Differentiation 4 297-308.
17. Carrier M, Emery RW, Wild-Mobley J, Perotta NJ, Russell DH & Copeland JG 1987 Prolactin as a marker of rejection in human heart transplantation. Transplantation Proceedings 29 3442-3443.
18. Chang W-P & Clevenger CV 1996 Modulation of growth factor receptor function by isoform heterodimerization. Proceedings of the National Academy of Sciences of the USA 93 5947-5952.
19. Chang W-P, Ye Y & Clevenger CV 1998 Stoichiometric structure/function analysis of the prolactin receptor signaling domains by receptor chimeras. Molecular and Cellular Biology 18 896-905.
20. fyn is associated with prolactin receptor and is activated by prolactin stimulation of T-lymphocytes. Molecular Endocrinology 8 674-681.
21. Clevenger CV & Plank TL 1997 Prolactin as an autocrine/paracrine growth factor in breast tissue. Journal of Mammary Gland Biology and Neoplasia 2 59-68.
22. Clevenger CV, Russell DH, Appasamy PM & Prystowsky MB 1990 Regulation of IL2-driven T-lymphocyte proliferation by prolactin. Proceedings of the National Academy of Sciences of the USA 87 6460-6464.
23. Clevenger CV, Altmann SW & Prystowsky MB 1991 Requirement of nuclear prolactin for interleukin-2-stimulated proliferation of T lymphocytes. Science 253 77-79.
24. Clevenger CV, Sillman AL, Hanley-Hyde J & Prystowsky MB 1992 Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes. Endocrinology 130 3216-3222.
25. Clevenger CV, Chang W-P, Ngo W, Pasha TLM, Montone KT & Tomaszewski JE 1995a Expression of prolactin and prolactin receptor in human breast carcinoma: Evidence for an autocrine/paracrine loop. American Journal of Pathology 146 1-11.
26. Clevenger CV, Ngo W, Sokol DL, Luger SM & Gewirtz AM 1995b Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. Journal of Biological Chemistry 270 13246-13253.
27. Clevenger CV, Thickman K, Ngo W, Chang W-P, Takayama S & Reed JC 1997 Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2. Molecular Endocrinology 11 608-618.
28. Comsa J, Leonhardt H & Schwarz JA 1975 Influence of the thymus-corticotropin-growth hormone interaction on the rejection of skin allografts in the rat. Annals of the New York Academy of Sciences 249 387-401.
29. Coppola J, Bryant S, Koda T, Conway D & Barbacid M 1991 Mechanism of activation of the vav protooncogene. Cell Growth and Differentiation 2 95-105.
30. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS & Bustelo XR 1997 Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385 169-172.
31. Dardenne M, de Morales MCL, Kelly PA & Gagnerault M-C 1994 Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorimetry. Endocrinology 134 2108-2114.
32. Darnell JE, Kerr IM & Stark GR 1994 JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 1415-1421.
33. DaSilva L, Howard OMZ, Rui H, Kirken RA & Farrar WL 1994 Growth signaling and JAK2 association mediated by membraneproximal cytoplasmic regions of prolactin receptors. Journal of Biological Chemistry 269 18267-18270.
34. Devins SS, Miller A, Herndon BL, O'Toole L & Reisz G 1992 Effects of dopamine on T-lymphocyte proliferative response and serum prolactin concentrations in critically ill patients. Critical Care Medicine 20 1644-1649.
35. Di Carlo R, Meli R, Galdiero M, Nuzzo I, Bentivoglio C & Carratelli CR 1993 Prolactin protection against lethal effects of Salmonella typhimurium. Life Sciences 53 981-989.
36. DiMattia GE, Gellersen B, Bohnet HG & Friesen HG 1986 A human B-lymphoblastoid cell line produces prolactin. Endocrinology 122 2508-2517.
37. Elberg G, Kelly PA, Djiane J, Binder L & Gertler A 1990 Mitogenic and binding properties of monoclonal antibodies to the prolactin receptor in Nb2 rat lymphoma cells. Journal of Biological Chemistry 265 14770-14776.
38. Erwin RA, Kirken RA, Malbarba MG, Farrar WL & Rui H 1995 Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology 136 3512-3518.
39. Evans GA, Howard OZM, Erwin R & Farrar WL 1993 Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck. Biochemical Journal 294 339-342.
40. Evans-Storms RB & Cidlowski JA 1995 Regulation of apoptosis by steroid hormones. Journal of Steroid Biochemistry and Molecular Biology 53 1-6.
41. Feig LA 1994 Guamne-nucleotide exchange factors: a family of positive regulators of Ras and related GTPases. Current Opinion in Cell Biology 6 204-211.
42. Fletcher-Chiappini SE, Comptom MM, Lavoie HA, Day EB & Witorsch RJ 1993 Glucocorticoid-prolactin interactions in Nb2 lymphoma cells: Antiproliferative versus anticytolytic effects. Proceedings of the Society for Experimental Biology and Medicine 202 345-352.
43. Fujii H, Nakagawa Y, Schindler U, Kawahara A, Mori H, Bouilleux F, Groner B, Ihle JN, Minami Y, Miyazaki T & Taniguchi T 1995 Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukm 2 receptor β chain but is not essential for the proliferative signal transmission. Proceedings of the National Academy of Sciences of the USA 92 5482-5486.
44. Gala RR 1991 Prolactin and growth hormone in the regulation of the immune system. Proceedings of the Society for Experimental Biology and Medicine 198 513-527.
45. Gellersen B, Kempf R, Telgmann R & DiMattia GE 1994 Nonpituitary human prolactin gene transcription is independent of pit-1 and differentially controlled in lymphocytes and in endometrial stoma. Molecular Endocrinology 8 356-373.
46. Gellersen B, Kempf R, Telgmann R & DiMattia GE 1995 Pituitary-type transcription of the human prolactin gene in the absence of Pit-1. Molecular Endocrinology 9 887-901.
47. Gilmour KC & Reich NC 1994 Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors. Proceedings of the National Academy of Sciences of the USA 91 6850-6854.
48. Ginsburg E & Vonderhaar BK 1995 Prolactin synthesis and secretion by human breast cancer cells. Cancer Research 55 2591-2595.
49. Glick B 1984 Interrelation of the avian immune and neuroendocrine systems. Journal of Experimental Zoology 232 671-682.
50. Gulbins E, Coggeshall KM, Baier G, Katzav S, Burn P & Altman A 1993 Tyrosine-kinase stimulated guanine nucleotide exchange activity of vav in T cell activation. Science 260 822-825.
51. Gulbins E, Coggeshall KM, Baier G, Telford D, Langlet C, Baier-Bitterlich G, Bonnefoy-Berard N, Burn P, Wittinghofer A & Altman A 1994a Direct stimulation of vav guanine nucleotide exchange activity for ras by phorbol esters and diglycerides. Molecular find Cellular Biology 14 4749-4758.
52. Gulbins E, Coggeshall KM, Laglet C, Baier G, Bonnefoy-Berard N, Burn P, Wittinghoffer A, Katzav S & Altman A 1994b Activation of Ras in vitro and in intact fibroblasts by the vav guanine nucleotide exchange protein. Molecular and Cellular Biology 14 906-913.
53. Gulbins E, Langlet C, Baier G, Bonnefoy-Berard N, Herbert E, Altman A & Coggeshall EM 1994c Tyrosine phosphorylation and activation of vav GTP/GDP exchange activity in antigen receptor-triggered D cells. Journal of Immunology 152 2123-2129.
54. Hartmann DP. Holoday JW & Bernton EW 1989 Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB Journal 3 2194-2202. Hobert O, Jallal B, Schlessinger J & Ullnch A 1994 Novel signaling pathway suggested by SH3 domain-mediated p95vav/heterogeneous ribonucleoprotein K interaction. Journal of Biological Chemistry 269 20225-20228.
55. Hartmann DP. Holoday JW & Bernton EW 1989 Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB Journal 3 2194-2202. Hobert O, Jallal B, Schlessinger J & Ullnch A 1994 Novel signaling pathway suggested by SH3 domain-mediated p95vav/heterogeneous ribonucleoprotein K interaction. Journal of Biological Chemistry 269 20225-20228.
56. Hobert O, ]allal B & Ullrich A 1996 Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression. Molecular and Cellular Biology 16 3066-3073.
57. Horseman ND, Zhao W, Montecino-Rodriguiez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E & Dorshkind K 1997 Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO Journal (In Press).
58. Ihle JN & Kerr IM 1995 Jaks and Stats in signaling by the cytokine receptor superfamily. Trends in Genetics 11 69-74.
59. Kant GJ, Bauman RA, Anderson SM & Mougey EH 1992 Effects of controllable vs uncontrollable chronic stress on stress-responsive plasma hormones. Physiology and Behavior 51 1285-1288.
60. Katzav S 1993 Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav. Oncagene 8 1757-1763.
61. Katzav S, Martin-Zanca D & Barbacid M 1989 Vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO Journal 8 2283-2290.
62. Katzav S, Cleveland JL, Heslop HE & Pulido D 1991 Loss of the ammo-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Molecular and Cellular Biology 11 1912-1920.
63. Kenner JR, Holaday JW, Bernton EW & Smith PF 1991 Prolactin-like protein in murine splenocytes: Morphologic and biochemical evidence. Progress in Neuroendocrinoimmunolagy 3 188-195.
64. Kooijman R, Hooghe-Peters EL & Hooghe R 1996 Prolactin, growth hormone, and insulin-like growth factor-1 in the immune system. Advances in Immunology 63 377-454.
65. Lebrun JJ, Ali S, Sofer L, Ullrich A & Kelly PA 1994 Prolactin-induced proliferation Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. Journal of Biological Chemistry 269 14021-14026.
66. Leff MA, Buckley DJ, Krumenacker JS, Reed JC, Miyashita T & Buckley AR 1996 Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology 137 5456-5462.
67. Lesueur L, Edery M, Ali S, Paly J, Kelly PA & Djiane J 1991 Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proceedings of the National Academy of Sciences of the USA 88 824-828.
68. Li B-Q, Subleski M, Fusaki N, Yamamoto T, Copeland T, Princler GL, Kung H-F & Kamata T 1996 Catalytic activity of the mouse guanine nucleotide exchanger mSOS is activated by Fyn tyrosine protein kinase and the T-cell antigen receptor in T-cells. Proceedings of the National Academy of Sciences of the USA 93 1001-1005.
69. McMurray R, Keisler D, Kanuckel K, Izui S & Walker SE 1992 Prolactin influences autoimmune disease activity in the female b/w mouse. Journal of Immunology 147 3780-3787.
70. McMurray RW, Keisler D, Izui S & Walker SE 1993 Effects of parturition, suckling, and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus. Journal of Rheumatology 20 1143-1151.
71. McMurray RW, Weidensaul D, Allen SH & Walker SE 1995 Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. Journal of Rheumtology 22 2084-2091.
72. Margolis B, Hu P, Katzav S, Li W, Oliver JM, Ullrich A, Weiss A & Schlessinger J 1992 Tyrosine phosphorylation of vav protooncogene product containing SH-2 domain and transcription factor motifs. Nature 356 71-74.
73. Martinelli GP, Lui H, Clarke WP, Heisenleder DJ & Knight RJ 1996 Prolactin suppression enhances the effects of perioperative donor-specific blood transfusion on graft survival. Journal of Surgical Research 64 190-197.
74. Matera L, Cesano A, Bellone G & Oberholtzer E 1992 Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B and NK lymphocytes. Brain, Behavior and Immunity 6 409-417.
75. Mershon J, Sall W, Mitchner N & Ben-Jonathan N 1995 Prolactin is a local growth factor in rat mammary tumors. Endocrinology 136 3619-3623.
76. Miura O, Cleveland JL & Ihle JN 1993 Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors. Molecular Cell Biology 13 1788-1795.
77. Montgomery DW, Zukoski CF, Shah GN, Buckley AR, Pacholczyk T & Russell DH 1987 Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity. Biochemical and Biophysical Research Communications 145 692-698.
78. Nagano M & Kelly PA 1994 Tissue distribution and regulation of rat prolactin receptor gene expression. Journal of Biological Chemistry 269 13337-13345.
79. Nagy E & Berczi I 1991 Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 128 2776-2784.
80. Nagy E, Berczi I, Wren GE, Asa SL & Kovacs K 1983 Immunomodulation by bromocriptine. Immnnopharmacology 6 231-243.
81. Nicoll CS 1974 Physiological actions of prolactin. Handbook of Physiology, edn 7, pp 253-291. Washington, DC: American Physiological Society.
82. Olivier R, Otter I, Monney L, Wartmann M & Borner C 1997 Bcl-2 does not require Raf kinase activity for its death-protective function. Biochemical Journal 324 75-83.
83. O'Neal KD & Yu-Lee L-Y 1994 Differential signal transduction of the short, Nb2, and long prolactin receptors. Journal of Biological Chemistry 269 26076-26082.
84. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N &: Kelly PA 1997 Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes and Development 11 167-178.
85. Pellegrini I, Lebrun J-J, Ali S & Kelly PA 1992 Expression of prolactin and its receptor in human lymphoid cells. Molecular Endocrinology 6 1023-1031.
86. Platanias LC & Sweet MC 1994 Interferon α induces rapid tyrosme phosphorylation of the vav proto-oncogene product in hematopoietic cells. Journal of Biological Chemistry 269 3143-3146.
87. Prystowskv MB & Clevenger CV 1994 Prolactin as a second messenger for mterleukin 2. Immunomethods 5 49-55.
88. Quelle FW, Wang D, Nosaka T, Thierfelder WE, Stravopodis D, Weinstein Y & Ihle IN 1996 Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Molecular and Cellular Biology 16 1622-1631.
89. Ramos-Morales F, Druker BJ & Fischer S 1994 Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. Oncogene 9 1917-1923.
90. Riddle O & Braucher PF 1931 Studies on the physiology of reproduction in birds. XXX. Control of the special secretion of the crop-gland in pigeons by an anterior pituitary hormone. American Journal of Pliysiology 97 617-625.
91. Riddle O, Bates RW & Dykshorn SW 1933 The preparation, identification and assay of prolactin - a hormone of the anterior pituitary. American Journal of Physiology 105 191-216.
92. Rui H, Kirken RA & Farrar WL 1994a Activation of receptor-associated tyrosine kinase JAK2 by prolactin. Journal of Biological Chemistry 269 5364-5368.
93. Rui H, Lebrun J-J, Kirken RA, Kelly PA & Farrar WL 1994b JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. Endocrinology 135 1299-1306.
94. Russell DH, Matrisian L, Kibler R, Larson DF, Poulos B & Magun BE 1984 Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochemical and Biophysical Research Communications 121 899-906.
95. Silvennomen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T & Ihle JN 1993 Structure of the munne Jak2 protein tyrosine-kinase and its role in interleukin 3 signal transduction. Proceedings of the National Academy of Sciences of the USA 90 8429-8433.
96. Skwarlo-Sonta K 1990 Mitogenic effect of prolactin on chicken lymphocytes in vitro. Immunology Letters 24 171-178.
97. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T, Ren R, Baltimore D, Ratnofsky S, Feldman RA & Cantley LC 1994 Specific motifs recognized by the SH2 domains of Csk, 3BP2, pfs/fes, Grb2, HCP, She, Syk amd Vav. Molecular and Cellular Biology 14 2777-2785.
98. Takayama S, Sato T, Krajewski S, Kochei K, Irie S, Millan JA & Reed JC 1995 Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity. Cell 80 279-284.
99. Telgmann R, Maronde E, Tasken K & Gellersen B 1997 Activated protein kinase A is required for differentiation-dependent transcription of the decidual prolactin gene in human endometrial stromal cells. Endocrinology 138 929-937.
100. Wang H-G, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S, Tanaka S, Hovey L, Troppmair J, Rapp U & Reed JC 1994 Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 9 2751-2756.
101. Wang H-G, Takayama S, Rapp UK & Reed JC 1996 Bcl-2 interacting protein, Bag-1, binds to and activates the kinase Raf-1. Proceedings of the National Academy of Sciences of the USA 93 7063-7068.
102. Wang X-J, Fuhrer DK, Marshall MS & Yang U-C 1997 Interleukin-11 induces complex formation of Grb2, Fyn, and JAK2 in 3T3L1 cells. Journal of Biological Chemistry 270 27999-28002.
103. Witorsch RJ, Day EB, Lavoie HA, Hashemi N & Taylor JK 1993 Comparison of glucocorticoid-induced effects in prolactin-dependent and autonomous rat Nb2 lymphoma cells. Proceedings of the Society far Experimental Biology and Medicine 203 454-460.
104. Wulf GM, Adra CN & Lim B 1993 Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA. EMBO Journal 12 5065-5074.
105. Wyllie AH 1980 Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuciease activation. Nature 284 555-556.
106. ras-dependent manner. Proceedings of the National Academy of Sciences of the USA 93 11681-11686.
107. Yu-Lee L-Y 1990 Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells. Molecular and Cellular Endocrinology 68 21-28.
108. Yu-Lee LY 1997 Molecular actions of prolactin in the immune system. Proceedings of the Society for Experimental Biology and Medicine 215 35-52.
109. Zeiner M & Gehring U 1995 A protein that interacts with members of the nuclear hormone receptor family: Identification and cDNA cloning. Proceedings of the National Academy of Sciences of the USA 92 11465-11469.
110. Zellweger R, Wichman MW, Ayala A, DeMaso CM & Chaudry IH 1996 Prolactin: A novel and safe immunomodulating hormone for the treatment of immunodepression following severe hemorrhage. Journal of Surgical Research 63 53-58.
111. Zhang R, Tsai F-Y & Orkin SH 1994 Hematopoietic development of vav ± / ± mouse embryonic stem cells. Proceedings of the National Academy of Sciences of the USA 91 12755-12759.
112. Zhang R, Alt FW, Davidson L, Orkin SH & Swat W 1995 Defective Signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374 470-473.